PDGFRB and neoplasm: As expected, α6-integrin is expressed on tumour endothelial cells, shown by co-expression of α6-integrin and the endothelial cell marker CD31 (Fig. S2C), suggesting that the deletion of α6-integrin in vivo was restricted to PDGFRβ-positive pericytes.